David Davenport
Director, US Policy Alliance for Regenerative Medicine
As Director, U.S. Policy at the Alliance for Regenerative Medicine (ARM), David collaborates with ARM’s internal and external stakeholders to develop, drive, and execute ARM’s strategy for advancing its U.S. policy objectives at the federal level, with a focus on access and reimbursement issues impacting cell and gene therapy. He brings a decade of policy and government affairs expertise, with a track record of influencing policymakers and driving consensus across diverse stakeholders to improve the health care patients receive.
